Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 3 of 3 citing Kim: Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic.... (0.13 sec) 

C-peptide levels and insulin independence following autologous nonmyeloablative …

- hbi.ir [PDF] 
CEB Couri, MCB Oliveira, ABPL Stracieri, DA … - JAMA, 2009 - Am Med Assoc
Context In 2007, the effects of the autologous nonmyeloablative hematopoietic
stem cell transplantation (HSCT) in 15 patients with type 1 diabetes mellitus
(DM) were reported. Most patients became insulin free with normal levels of ...
Cited by 12 - Related articles - All 4 versions

Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor …


WL Suarez-Pinzon, GS Cembrowski, A … - Diabetologia, 2009 - Springer
Page 1. RESEARCH LETTER Combination therapy with a dipeptidyl peptidase-4
inhibitor and a proton pump inhibitor restores normoglycaemia ...
Related articles - All 2 versions

Stem cell therapy for type 1 diabetes mellitus: a review of recent clinical trials


CEB Couri, JC Voltarelli - Diabetology and Metabolic Syndrome, 2009 - ukpmc.ac.uk
Stem cell therapy is one of the most promising treatments for the near future.
It is expected that this kind of therapy can ameliorate or even reverse some
diseases. With regard to type 1 diabetes, studies analyzing the therapeutic ...
Related articles - All 3 versions


 


Go to Google Home - About Google - About Google Scholar

©2009 Google